152 related articles for article (PubMed ID: 18373227)
1. Chronic myeloid leukemia following the treatment of rectal adenocarcinoma.
Kadikoylu G; Yavasoglu I; Barutca S; Meydan N; Bolaman Z
Med Oncol; 2008; 25(4):467-70. PubMed ID: 18373227
[TBL] [Abstract][Full Text] [Related]
2. Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.
Wong SJ; Moughan J; Meropol NJ; Anne PR; Kachnic LA; Rashid A; Watson JC; Mitchell EP; Pollock J; Lee RJ; Haddock M; Erickson BA; Willett CG
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):116-23. PubMed ID: 25446610
[TBL] [Abstract][Full Text] [Related]
3. Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiers.
Ducreux M; Köhne CH; Schwartz GK; Vanhoefer U
Ann Oncol; 2003; 14 Suppl 2():ii17-23. PubMed ID: 12810453
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.
Heudel P; Romestaing P; Barbet N; Falandry C; You B; Glehen O; Freyer G
Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):369-74. PubMed ID: 18406583
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer].
Zhao WY; Chen DY; Qi Q
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):295-8. PubMed ID: 21575503
[TBL] [Abstract][Full Text] [Related]
6. 25th European Society for Medical Oncology Congress. Hamburg, Germany. October 13-17, 2000.
D'Orazio AI; Gambill BD
Clin Colorectal Cancer; 2001 May; 1(1):10-5. PubMed ID: 12445373
[No Abstract] [Full Text] [Related]
7. The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.
Clin Colorectal Cancer; 2003 Feb; 2(4):205-9. PubMed ID: 12620138
[No Abstract] [Full Text] [Related]
8. Treatment of colorectal cancer metastasis: the role of chemotherapy.
Xiong HQ; Ajani JA
Cancer Metastasis Rev; 2004; 23(1-2):145-63. PubMed ID: 15000155
[TBL] [Abstract][Full Text] [Related]
9. New oxaliplatin-based combinations in the treatment of colorectal cancer.
Cassidy J; Hochster H
Colorectal Dis; 2003 Nov; 5 Suppl 3():1-9. PubMed ID: 23573555
[TBL] [Abstract][Full Text] [Related]
10. Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
Comella P; Massidda B; Filippelli G; Farris A; Natale D; Barberis G; Maiorino L; Palmeri S; Cannone M; Condemi G;
J Cancer Res Clin Oncol; 2009 Feb; 135(2):217-26. PubMed ID: 18719941
[TBL] [Abstract][Full Text] [Related]
11. [New therapeutic options in chemotherapy of advanced colorectal cancer].
Reimer P; Rückle-Lanz H
Med Klin (Munich); 2001 Oct; 96(10):593-8. PubMed ID: 11715331
[TBL] [Abstract][Full Text] [Related]
12. Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer.
Volk J; Reinke F; van Kuilenburg AB; van Gennip AH; Schlichting C; Ganser A; Schöffski P
Ann Oncol; 2001 Apr; 12(4):569-71. PubMed ID: 11398894
[TBL] [Abstract][Full Text] [Related]
13. Highlights from: 27th congress of the European Society for Medical Oncology. Nice, France. October 18-22, 2002.
Maung K; Lee D; DeGrendele HC; Schilsky R; Chu E; Jain VK; Copur S
Clin Colorectal Cancer; 2002 Nov; 2(3):140-5. PubMed ID: 12482329
[No Abstract] [Full Text] [Related]
14. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
15. Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracil.
Pfeiffer P; Sørbye H; Ehrsson H; Fokstuen T; Mortensen JP; Baltesgard L; Tveit KM; Øgreid D; Starkhammar H; Wallin I; Qvortrup C; Glimelius B
Ann Oncol; 2006 Feb; 17(2):252-8. PubMed ID: 16291583
[TBL] [Abstract][Full Text] [Related]
16. [A review of chemotherapy for metastatic colon cancer].
Díez-Fernández R; Salinas Hernández P; Girón-Duch C
Farm Hosp; 2006; 30(6):359-69. PubMed ID: 17298193
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine in combination with irinotecan or oxaliplatin in advanced colorectal cancer.
Clin Colorectal Cancer; 2003 Aug; 3(2):89-91. PubMed ID: 12952563
[No Abstract] [Full Text] [Related]
18. [Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].
Li YH; An X; Xiang XJ; Wang ZQ; Wang FH; Feng F; Jiang WQ; He YJ; Xu RH
Ai Zheng; 2009 Sep; 28(9):939-44. PubMed ID: 19728911
[TBL] [Abstract][Full Text] [Related]
19. Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines.
Ransom D; Wilson K; Fournier M; Simes RJ; Gebski V; Yip D; Tebbutt N; Karapetis CS; Ferry D; Gordon S; Price TJ
Ann Oncol; 2014 Jan; 25(1):117-21. PubMed ID: 24299960
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer.
Bajetta E; Celio L; Ferrario E; Di Bartolomeo M; Denaro A; Dotti K; Mancin M; Bajetta R; Colombo A; Pusceddu S
Ann Oncol; 2007 Nov; 18(11):1810-6. PubMed ID: 17823385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
